Tom Curtis Email & Phone Number

San Antonio, TX, US

Irvine, California, US

Marketing and commercialization for nRichDX and the Revolution Sample Prep System™. Purpose-built for liquid biopsy applications, the IVD-labeled Revolution System and innovative nRicher Cartridge™ provide higher yields and earlier detection of rare analytes, like cfDNA and cfRNA, from blood or urine specimens.

I enjoy helping start-up life sciences companies develop unique products and brands and implementing the commercial tactics that help them rapidly grow. I have years of life sciences and diagnostics marketing and commercial experience with both start-ups and industry leaders. Early-stage companies and pilot projects require experienced strategic.

Frederick, Maryland, US

• Recruited into Marketing Leadership of this start-up on a fast growth trajectory.RoosterBio supplies cells, media systems, bioprocesses, and development services for the growth and expansion of mesenchymal stem/stromal.
• Built a highly effective marketing team with "immediate impact" on marketing performance.
• Grew brand awareness from est. 2% - 3% to more than 20% through integrated marketing of social media, event/conference marketing, and inbound marketing content generation.
• Designed and implemented a tailored, scalable phase-gate product development and launch process ("CDL") enabling a faster cadence of new product launches with improved leadership oversight.
• Sourced and deployed collaboratively with Sales colleagues a better-fit CRM and Marketing Automation solution within first 3 months of tenure, saving an estimated $270k and speeding-up deployment and operational use by.

Austin, TX, US

• Lifespan offered parents complete DNA sequencing of their newborn children using a "freemium" business model. Lifespan provided information products from the genome to the child's parents and doctors when it was wanted.
• Attracted a team of experienced co-founders and advisors.
• Successfully negotiated a unique, multi-million dollar deal with a Next-Generation Sequencing (NGS) category leader.
• Created a best-of-class financial model and concise investment pitch deck in a technically challenging subject area and pitched to prospective investors and partners including C-Suite executives, HNW individuals.
• Sourced and implemented a secure genome data warehouse, and bioinformatics analysis pipeline to house and process individual genome data.
• Created Minimum Viable Product (MVP), attractive marketing and sales collateral, website, and social media presence and neonatal/pediatric sample collection kit.

Austin, Texas, US

• Sonic Healthcare USA at the time was the $800M U.S. Division of Sonic Healthcare, headquartered in Sydney, Australia. Sonic Healthcare USA was an organization of 6,100 employees with the distinction of being the.
• Established and led Sonic Healthcare USA's first national and corporate marketing group implementing brand consistency, sales enablement and demand lead generation tactics across all the Sonic Healthcare USA federation.
• Secured support and led marketing efforts for the launch of Sonic Reference Laboratory as theorganization's molecular diagnostics (Mol Path / MDx) commercialization expert with the 2014 launch of Sonic's new.
• Implemented secure, mobile (SaaS) sales enablement platform putting electronic versions of all sales support collateral and secure online communications for 300+ marketing and sales staff.
• Created and led implementation of Direct-to-Consumer (DTC) strategy increasing customer satisfaction.

• CBLPath joined the Sonic Healthcare federation of laboratories in November 2010. CBLPath was an $85M lab operation at the time. The CBLPath lab brand is still in existence within the Sonic Healthcare USA.
• Hired and led a first-class staff of product managers and marketing communications team.
• Contracted and managed CBLPath's first Agency of Record (AOR).
• Led molecular oncology diagnostics (Mol Path / MDx) marketing effort.

Venlo, Limburg, NL

I was recruited into Qiagen by my former manager at Life Technologies (LTI) due to my unique sales and marketing talents and scientific background in the field. Qiagen was focused on expansion of its DNA and RNA extraction and analysis tools and especially its growing automation / instrumentation platforms in multiple life sciences markets. What started as.

In the early 2000's, Nanogen was a $35M pioneer in electronic microarrays for life science applications, including diagnostics. In 2004, they merged with Epoch Biosciences. Here, I championed the commercial drive into molecular diagnostics (Mol Path / MDx) and was promoted from Product Manager to Associate Director during my tenure. I led a team of Product.

Waltham, MA, US

Life Technologies; enzymes and automation in the Industrial BioProducts (IBP) segment. Life Technologies was acquired and today is a division within Thermo Fisher Scientific.

Rockville, MD, US

Recruited by OriGene Founder and previously laboratory colleague at HGS. OriGene focuses on tools for genetic / genomic and life-sciences applications at scale.

Chicago, US

Amersham Pharmacia was acquired and today is part of GE Healthcare.

Rockville, MD, US

Successful pioneer in genomic discovery and translation to clinical applications. HGS was acquired and today is part of GlaxoSmithKline.

Bachelor Of Science (B.Sc.), Biochemistry

Marketing